Repermeation of partially embolized cerebral arteriovenous malformations: A clinical, radiologic, and histologic study

American Journal of Neuroradiology

Volumn 17, Issue 7, 1996, Pages 1323-1331

  Gruber, Andreas ^a   Mazal, Peter R ^b   Bavinzski, Gerhard ^a   Killer, Monika ^a   Budka, Herbert ^b   Richling, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arteriovenous malformations, cerebral; Arteriovenous malformations, embolization

Indexed keywords

ENBUCRILATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD; MICROSURGERY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; CHILD; EMBOLIZATION, THERAPEUTIC; ENBUCRILATE; FEMALE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; REPERFUSION; RETROSPECTIVE STUDIES;

EID: 0029799172     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Picard L, Moret J, Lepoire J. Endovascular treatment of intracerebral arteriovenous malformations. J Neuroradiol 1984;11:9-28
2. Deruty R, Lapras C, Pierluca P, Patet JD, Pialat J, Garcia C. Embolisation preoperatoire des malforations arterio-veineuses cerebrales par le butyl-cyanoacrylate. Neurochirurgie 1985;31: 21-29
3. Spetzler RF, Martin N, Carter LP, Flom R, Raudzens P, Wilkinson E. Surgical management of large AVMs by staged embolization and operative excision. J Neurosurg 1987;67:17-28
4. Vinuela F, Dion J, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience in 101 cases. J Neurosurg 1991;75:856-864
5. Lunsford LD, Kondziolka D, Flickinger J, Bissonette D. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991;75:512-524
6. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994; 34:2-7
7. Marks M, Lane B, Steinberg G, Chang P. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology 1990;176:807-813
8. Vinuela F, Nombela L, Roach M, Fox A, Pelz D. Stenotic and occlusive disease of the venous drainage system of deep brain AVMs. J Neurosurg 1985;63:180-184
9. Spetzler RF, Martin N. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-483
10. Spiegel SM, Vinuela F, Goldwasser JM, Fox AJ. Adjusting the polymerization time of isobutyl-2-cyanoacrylate. AJNR Am J Neuroradiol 1986;7:109-112
11. Hieshima GB, Reicher MA, Higashida RT, Halbach VV. Intraoperative digital subtraction neuroangiography: a diagnostic and therapeutic tool. AJNR Am J Neuroradiol 1987;8:759-767
12. Lundie MJ, Ellyatt D, Kaufmann JCE, Vinters HV. Staining procedure to aid in assessment of bucrylate histotoxicity in tissue sections. Arch Pathol Lab Med 1985;109:779-781
13. Brothers MF, Kaufmann JC, Fox AJ, Deveikis JP. n-Butyl 2-cyanoacrylate: substitute for IBCA in interventional neuroradiology: topographic and polymerization time study. AJNR Am J Neuroradiol 1989;10:777-786
14. Klara PM, Eugene DJ, McDonnell DE, Pevsner PH. Morphological studies of human arteriovenous malformations: effects of isobutyl 2-cyanoacrylate embolization. J Neurosurg 1985;63:421-425
15. Schweitzer JS, Chang BS, Madsen P, Vinuela F, Martin NA, Vinters HV. The pathology of arteriovenous malformations of the brain treated by embolotherapy, II: results of embolization with multiple agents, Neuroradiology 1993;35:468-474
16. Clarisse J, Gozet G, Cornil J, Jomin P, Delandsheer J, Laines E. Les emboles plastiques fluides: etude experimentale et rapport de deux cas cliniques de fistules arterio-veineuses traintees. J Neuroradiol 1975;2:29-38
17. Germano LM, Davis RL, Wilson CB, Hieshima GB. Histopathological follow up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol. J Neurosurg 1992;76:607-614
18. Lylyk P, Vinuela F, Vinters HV, Dion J, Duckwiler C, Lin T. Use of a new mixture for embolization of intracranial vascular malformations, Neuroradiology 1990;32:304-310
19. Taki W, Kikuchi H, Iwata H, Nishi S. Embolization of arteriovenous malformations using EVAL mixture (a new liquid embolization material). Neuroradiology 1991;33(Suppl):195-196
20. Suzuki J, Komatsu S. New embolization method using estrogen for dural arteriovenous malformations and meningiomas. Surg Neurol 1981;16:438-442
21. Richling B. Homologous controlled viscosity fibrin for endovascular embolization. Acta Neurochir (Wien) 1982;62:159-170
22. Mickey BE, Samson D. Neurosurgical applications of the cyanoacrylate adhesives. Clin Neurosurg 1981;28:429-444
23. Pevsner PH, George ED, Doppmann JL. Interventional radiology polymeric update: acrylic. Neurosurgery 1982;10:314-316
24. Vinters H, Lundie MJ, Kaufmann J. Long term pathological follow up of cerebral arteriovenous malformations treated by embolization with bucrylate. N Engl J Med 1986;314:477-483
25. Diaz FG, Mastri AR, Chou SN. Neural and vascular tissue reactions to aneurysm coating adhesive (ethyl-2-cyanoacrylate). Neurosurgery 1978;3:45-49
26. Green AR, Milling MA. Butyl cyanoacrylate adhesives in microvascular surgery: an experimental pilot study. J Reconstr Microsurg 1986;2:103-105
27. Hood T, Mastri A, Chou S. Neural and vascular tissue reactions to cyanoacrylate adhesives: a further report. Neurosurgery 1982;11: 363-366
28. Lanman TH, Martin NA, Vinters HV. The pathology of encephalic arteriovenous malformations treated by prior embolotherapy. Neuroradiology 1988;30:1-10
29. Vinters H, Galil K, Lundie M, Kaufmann JCE. The histotoxicity of cyanoacrylates, a selective review. Neuroradiology 1985;27: 279-291
30. Vinters H, Debrun G, Kaufmann J, Drake C. Pathology of arteriovenous malformations embolized with isobutyl-2- cyanoacrylate (bucrylate). J Neurosurg 1981;55:819-825
31. Zanetti P, Sherman F. Experimental evaluation of a tissue adhesive as an agent for the treatment of aneurysms and arteriovenous abnormities. J Neurosurg 1972;36:72-76
32. Zumpano J, Jacobs L, Hall J, Margolis G, Sachs E Jr. Bioadhesive and histotoxic properties of ethyl-2-cyanoacrylate. Surg Neurol 1982;18:452-457
33. Fournier D, Terbrugge K, Rodesch G, Lasjaunias P. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology 1990;32:497-501
34. Rao VRK, Mandalam KR, Gupta AK, Kumar S. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol 1989;10:135-141
35. Vinuela F, Fox AJ, Pelz D, Debrun G. Angiographic follow up of large cerebral AVMs incompletely embolized with isobutyl-2-cyanoacrylate. AJNR Am J Neuroradiol 1986;7:919-925
36. Neufeld G, Tessler S, Gitay-Goren H, Levi BZ. Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994; 5:89-97
37. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia induced angiogenesis. Nature 1992;29:843-845
38. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652
39. Weich HA, Iberg N, Klagsbrunn M, Folkman J. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J Cell Biochem 1991;47:158-164
40. Villaschi S, Nicosia RF. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993;143:181-190
41. RayChaudhury A, D'Amore PA. Endothelial cell regulation by transforming growth factor-beta. J Cell Biochem 1991;47:224-229
42. Iruela-Arispe ML, Sage EH. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF beta-1. J Cell Biochem 1993;52:414-430
43. Risau W, Drexler H, Mironov V, Heldin CH. Platelet derived growth factor is angiogenic in vivo. Growth Factors 1992;7:261-266
44. Sato N, Beitz JG, Kato J, Raymond A, Frackelton AR Jr. Platelet derived growth factor stimulates angiogenesis in vitro. Am J Pathol 1993;142:1119-1130
45. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994;55:410-422
46. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991;51:195-216
47. Rosen EM, Liu D, Setter E, Bhargava M, Goldberg ID. Interleukin-6 stimulates motility of vascular endothelium. EXS 1991;59: 194-205
48. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 1992;140:539-544
49. Ribatti D, Loria MP, Tursi A. Lymphocyte induced angiogenesis: a morphometric study in the chicken embryo chorioallantoic membrane. Acta Anat (Basel) 1991;142:334-338
50. Risau W. Angiogenesis and endothelial cell function. Arzneimittelforschung 1994;44:416-417
51. Ando J, Kamiya A. Blood flow and vascular endothelial cell function. Front Med Biol Eng 1993;5:245-264
52. Gimbrone MA Jr. Platelet-derived growth factor beta chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A 1993;90:4591-4595
53. Ciricillo SF, Edwards MS. Occult malformations with anomalous venous drainage (letter). J Neurosurg 1995;82:311-312
54. Wikholm G. Occlusion of cerebral arteriovenous malformations with n-butyl cyanoacrylate is permanent. AJNR Am J Neuroradiol 1995;16:479-482